These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 6243308

  • 1. Relationship between secretion of platelet Factor 4 and thrombin generation during in vitro blood clotting.
    Shuman MA, Levine SP.
    J Clin Invest; 1980 Feb; 65(2):307-13. PubMed ID: 6243308
    [Abstract] [Full Text] [Related]

  • 2. Thrombin generation and secretion of platelet Factor 4 during blood clotting.
    Shuman MA, Levine SP.
    J Clin Invest; 1978 Apr; 61(4):1102-6. PubMed ID: 207723
    [Abstract] [Full Text] [Related]

  • 3. The procoagulant effect of platelets on conversion of prothrombin to thrombin in nonanticoagulated plasma.
    White BN, Cox AC, Taylor FB.
    J Lab Clin Med; 1980 Jun; 95(6):827-41. PubMed ID: 7381294
    [Abstract] [Full Text] [Related]

  • 4. Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.
    Miletich JP, Majerus DW, Majerus PW.
    J Clin Invest; 1978 Oct; 62(4):824-31. PubMed ID: 701480
    [Abstract] [Full Text] [Related]

  • 5. Effects of heparin and hirudin on thrombin generation and platelet aggregation after intrinsic activation of platelet rich plasma.
    Gallistl S, Muntean W, Leis HJ.
    Thromb Haemost; 1995 Oct; 74(4):1163-8. PubMed ID: 8560429
    [Abstract] [Full Text] [Related]

  • 6. Factor XI enhances fibrin generation and inhibits fibrinolysis in a coagulation model initiated by surface-coated tissue factor.
    von dem Borne PA, Cox LM, Bouma BN.
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):251-7. PubMed ID: 16651866
    [Abstract] [Full Text] [Related]

  • 7. The measurement of thrombin in clotting blood by radioimmunoassay.
    Shuman MA, Majerus PW.
    J Clin Invest; 1976 Nov; 58(5):1249-58. PubMed ID: 993343
    [Abstract] [Full Text] [Related]

  • 8. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
    Vretenbrant K, Ramström S, Bjerke M, Lindahl TL.
    Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
    [Abstract] [Full Text] [Related]

  • 9. Thrombin-induced platelet factor Va formation in patients with a gray platelet syndrome.
    Baruch D, Lindhout T, Dupuy E, Caen JP.
    Thromb Haemost; 1987 Aug 04; 58(2):768-71. PubMed ID: 2445043
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of prothrombin activation by bothrojaracin, a C-type lectin from Bothrops jararaca venom.
    Monteiro RQ, Zingali RB.
    Arch Biochem Biophys; 2000 Oct 01; 382(1):123-8. PubMed ID: 11051105
    [Abstract] [Full Text] [Related]

  • 11. Effect of non-heparin thrombin antagonists on thrombin generation, platelet function, and clot structure in whole blood.
    Carr ME, Angchaisuksiri P, Carr SL, Martin EJ.
    Cell Biochem Biophys; 2003 Oct 01; 39(2):89-99. PubMed ID: 14515016
    [Abstract] [Full Text] [Related]

  • 12. Thrombin generation assay as a possible tool for assessment of reduced activity of clotting factors induced by antiphospholipid antibodies and in-vitro evaluation of treatment options.
    Livnat T, Zivelin A, Tamarin I, Guetta V, Salomon O.
    Blood Coagul Fibrinolysis; 2009 Dec 01; 20(8):661-6. PubMed ID: 19730246
    [Abstract] [Full Text] [Related]

  • 13. Thrombin generation in newborn plasma is critically dependent on the concentration of prothrombin.
    Andrew M, Schmidt B, Mitchell L, Paes B, Ofosu F.
    Thromb Haemost; 1990 Feb 19; 63(1):27-30. PubMed ID: 2339359
    [Abstract] [Full Text] [Related]

  • 14. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V, Pignatelli P, Lenti L, Ferro D, Bellia A, Carnevale R, Tesauro M, Sorge R, Lauro R, Violi F.
    Circulation; 2005 Feb 01; 111(4):412-9. PubMed ID: 15687128
    [Abstract] [Full Text] [Related]

  • 15. Platelets and phospholipids in tissue factor-initiated thrombin generation.
    Butenas S, Branda RF, van't Veer C, Cawthern KM, Mann KG.
    Thromb Haemost; 2001 Aug 01; 86(2):660-7. PubMed ID: 11522019
    [Abstract] [Full Text] [Related]

  • 16. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin.
    Baglia FA, Walsh PN.
    Biochemistry; 1998 Feb 24; 37(8):2271-81. PubMed ID: 9485373
    [Abstract] [Full Text] [Related]

  • 17. A possible mechanism of action of activated factor VII independent of tissue factor.
    Monroe DM, Hoffman M, Oliver JA, Roberts HR.
    Blood Coagul Fibrinolysis; 1998 Mar 24; 9 Suppl 1():S15-20. PubMed ID: 9819024
    [Abstract] [Full Text] [Related]

  • 18. Platelet-aggregating activities of metastasizing tumor cells. III. Platelet aggregation as resulting from thrombin generation by tumor cells.
    Tohgo A, Tanaka NG, Ogawa H.
    Invasion Metastasis; 1985 Mar 24; 5(2):96-105. PubMed ID: 3980164
    [Abstract] [Full Text] [Related]

  • 19. The role of platelet factor V in prothrombin conversion.
    Chesney CM, Pifer DD, Colman RW.
    Thromb Res; 1983 Jan 01; 29(1):75-84. PubMed ID: 6836546
    [Abstract] [Full Text] [Related]

  • 20. Relationship between platelet secretion and prothrombin cleavage in native whole blood.
    Rybak ME, Lau HK, Tomkins B, Rosenberg RD, Handin RI.
    J Clin Invest; 1981 Aug 01; 68(2):405-12. PubMed ID: 7263860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.